Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Biologics Analysis

Analyzing Biologics with state-of-the-art mass spectrometers

Syngene offers a range of biologics assays using top-down intact analysis or bottom-up tryptic digestion approaches to analyze biologics such as peptides, oligonucleotides, and monoclonal antibodies, based on their molecular weight. Our experts are well-versed in conducting assays that quantitatively analyze peptides using liquid chromatography with tandem mass spectrometry (LC-MS/MS). 

We use state-of-the-art triple quadrupole LC-MS/MS such as AB Sciex Triple Quad 6500+ as well as parallel technology quadrupole time-of-flight (QTOF) as it offers an advantage in initial method development and optimization. 

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details